93 related articles for article (PubMed ID: 9191303)
41. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
[TBL] [Abstract][Full Text] [Related]
42. Mapping of the genes encoding the HLA-DR alpha chain and the HLA-related antigens to a chromosome 6 deletion by using genomic blotting.
Erlich HA; Stetler D; Saiki R; Gladstone P; Pious D
Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2300-4. PubMed ID: 6403947
[TBL] [Abstract][Full Text] [Related]
43. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
Hammond C; Denzin LK; Pan M; Griffith JM; Geuze HJ; Cresswell P
J Immunol; 1998 Oct; 161(7):3282-91. PubMed ID: 9759843
[TBL] [Abstract][Full Text] [Related]
44. Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells.
Giacomini P; Aguzzi A; Ferrone S
Hybridoma; 1986; 5(4):277-88. PubMed ID: 3100420
[TBL] [Abstract][Full Text] [Related]
45. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains.
Douhan J; Hauber I; Eibl MM; Glimcher LH
J Exp Med; 1996 Mar; 183(3):1063-9. PubMed ID: 8642248
[TBL] [Abstract][Full Text] [Related]
46. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
47. Expression of HLA-DR antigens at the surface of mouse L cells co-transfected with cloned human genes.
Rabourdin-Combe C; Mach B
Nature; 1983 Jun 23-29; 303(5919):670-4. PubMed ID: 6304534
[TBL] [Abstract][Full Text] [Related]
48. Indirect recognition of native HLA alloantigens and B-cell help.
Suciu-Foca N; Liu Z; Harris PE; Reed EF; Cohen DJ; Benstein JA; Benvenisty AI; Mancini D; Michler RE; Rose EA
Transplant Proc; 1995 Feb; 27(1):455-6. PubMed ID: 7533416
[No Abstract] [Full Text] [Related]
49. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.
Moldenhauer G; Henne C; Karhausen J; Möller P
Immunology; 1999 Mar; 96(3):473-84. PubMed ID: 10233730
[TBL] [Abstract][Full Text] [Related]
50. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
51. Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex alpha/beta chains.
Sant AJ; Hendrix LR; Coligan JE; Maloy WL; Germain RN
J Exp Med; 1991 Oct; 174(4):799-808. PubMed ID: 1919435
[TBL] [Abstract][Full Text] [Related]
52. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
Guo TL; Mudzinski SP; Lawrence DA
Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
[TBL] [Abstract][Full Text] [Related]
53. Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells.
Kawai J; Ando A; Sato T; Nakatsuji T; Tsuji K; Inoko H
J Immunol; 1989 Jan; 142(1):312-7. PubMed ID: 2462589
[TBL] [Abstract][Full Text] [Related]
54. Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.
Machamer CE; Cresswell P
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1287-91. PubMed ID: 6608726
[TBL] [Abstract][Full Text] [Related]
55. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments.
Sanderson F; Kleijmeer MJ; Kelly A; Verwoerd D; Tulp A; Neefjes JJ; Geuze HJ; Trowsdale J
Science; 1994 Dec; 266(5190):1566-9. PubMed ID: 7985027
[TBL] [Abstract][Full Text] [Related]
56. Mutation in the class II trans-activator leading to a mild immunodeficiency.
Wiszniewski W; Fondaneche MC; Le Deist F; Kanariou M; Selz F; Brousse N; Steimle V; Barbieri G; Alcaide-Loridan C; Charron D; Fischer A; Lisowska-Grospierre B
J Immunol; 2001 Aug; 167(3):1787-94. PubMed ID: 11466404
[TBL] [Abstract][Full Text] [Related]
57. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
[TBL] [Abstract][Full Text] [Related]
58. Isolation of cDNA clones encoding HLA-DR alpha chains.
Wake CT; Long EO; Strubin M; Gross N; Accolla R; Carrel S; Mach B
Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6979-83. PubMed ID: 6817331
[TBL] [Abstract][Full Text] [Related]
59. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
Riberdy JM; Newcomb JR; Surman MJ; Barbosa JA; Cresswell P
Nature; 1992 Dec; 360(6403):474-7. PubMed ID: 1448172
[TBL] [Abstract][Full Text] [Related]
60. Invariant chain influences post-translational processing of HLA-DR molecules.
Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
